Psylo

psylo.bio

Psylo is a biotechnology company focused on developing neuroplastogens, a new class of therapies aimed at restoring brain function by stimulating the growth and remodeling of neural circuits. The company leverages a computationally-enhanced drug discovery platform to create rapid-acting serotonergic agents that address scalability and accessibility challenges associated with traditional psychedelics like psilocybin. Psylo's mission is to provide widely accessible medications that serve as improved alternatives to current SSRIs, positioning itself as a pioneer in the neuropsychiatric treatment space with a commitment to inclusive healthcare solutions.